Coca-Cola earnings, Google's AI risks, Target layoffs and more in Morning Squawk

In a busy start to the trading week, major developments are unfolding across various sectors that investors should keep an eye on. YouTube sensation MrBeast, known for his extravagant online persona, is venturing into banking with his acquisition of the financial app Step through his company, Beast Industries. As stock futures remain stable following a positive start to the week, tech stocks played a pivotal role in lifting the market. The S&P 500 achieved its second consecutive day of gains, while the Dow Jones Industrial Average celebrated new intraday and closing records. However, Coca-Cola's shares are under pressure after the company reported mixed results for its fourth quarter. Although adjusted earnings per share surpassed expectations, its adjusted revenue of $11.82 billion fell short of the $12.03 billion forecast by analysts. Looking ahead, Coca-Cola anticipates organic revenue growth of 4% to 5% by 2026, amid ongoing challenges as consumers tighten their grocery budgets. Meanwhile, Alphabet, Google's parent company, is poised to make significant investments in artificial intelligence, but not without acknowledging the associated risks. In its recent financial report, Alphabet warned that the increased use of generative AI could potentially disrupt its core advertising business. The tech giant is reportedly planning to raise $20 billion through a U.S. dollar bond sale to support its AI initiatives, with capital expenditures anticipated to more than double in 2026 compared to 2025. In the retail sector, Target is making strategic adjustments to enhance the in-store shopping experience. An internal memo revealed plans to bolster staffing levels while eliminating around 500 positions at distribution centers and regional offices. Newly appointed CEO Michael Fiddelke emphasized the importance of improving customer experiences, addressing concerns over disorganized shelves and lengthy checkout lines. Lastly, Novo Nordisk is facing scrutiny from the FDA regarding a television advertisement for its Wegovy pill, which the agency claims contains misleading statements. The company, while clarifying that the advertisement in question is not related to its high-profile Super Bowl spot, stated it is addressing the FDA's concerns. Shares of Novo Nordisk saw an increase of over 3% in the previous trading session, while Hims & Hers, facing legal action from Novo for a competing obesity pill, experienced a 16% drop in stock value. As the market evolves, these stories highlight the dynamic interplay of innovation, regulation, and consumer behavior shaping the business landscape.